Search

Author/Creator Rodríguez-Lago, I

1. DOP32 Long-term outcomes of enterocutaneous fistula complicating Crohn's Disease: The ECUFIT study from GETECCU. (27th May 2021)

Authors:
Rodríguez-Lago, I; García Pérez, C; Calafat, M; Soto, M P; Calvo, M; Sánchez Rodríguez, E; Caballol, B; Vela, M; Rivero, M; Muñoz, F; De Castro, L; Calvet, X; García-Alonso, F J; Utrilla Fornals, A; Ferreiro-Iglesias, R; González-Muñoza, C; Chaparro, M; Luis, B; Sicilia, B; Alfambra, E
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S070
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. DOP37 Large differences in IBD care and education across Europe, first results of the pan-European VIPER survey. (27th May 2021)

Authors:
Král, J; Nakov, R; Lanska, V; Barberio, B; Benech, N; Blesl, A; Brunet, E; Capela, T L; Derikx, L A A P; Dragoni, G; Eek, A; Frias-Gomes, C; Gîlcă-Blanariu, G E; Gilroy, L; Harvey, P R; Kagramanova, A; Kani, H T; Konikoff, T; Lessing, M; Madsen, G R
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S075
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. DOP40 Comorbidities and epidemiological risk factor but not immunosuppressive therapies increase the risk of COVID-19 in Inflammatory Bowel Disease (IBD): An ENEIDA-based, case-control study. (27th May 2021)

Authors:
Zabana Abdo, Y; Marín-Jiménez, I; Rodríguez-Lago, I; Vera, I; Martín, M D; Guerra, I; Gisbert, J P; Mesonero, F; Benítez, O; Taxonera, C; Ponferrada-Díaz, Á; Piqueras, M; Lucendo, A; Caballol, B; Mañosa, M; Martínez-Montiel, P; Bosca-Watts, M; Gordillo, J; Bujanda, L; Manceñido, N
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S078
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU. (27th May 2021)

Authors:
Zabana Abdo, Y; Marín-Jiménez, I; Rodríguez-Lago, I; Ramírez Esteso, F; Meijilde, S; Ramos, L; Gomollón, F; Muñoz, F; Suris, G; Ortiz de Zárate, J; Huguet, J M; Llaó, J; García-Sepulcre, M; Sierra, M; Durà, M; Estrecha, S; Fuentes Coronel, A; Hinojosa, E; Olivan, L; Iglesias, E
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S553
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. OP23 Asymptomatic inflammatory bowel disease diagnosed during the colorectal cancer population screening in Catalonia. (30th January 2023)

Authors:
Brunet, E; Selva, A; Bas-Cutrina, F; Brujats, A; Caballol, B; Gomez, B; Gonzalez, C; Busquets, D; Monfort, D; Vera, D P; Maristany, E; Cirera, G; Torres, G; Castro-Poceiro, J; Lopez, J; Gonzalez-Gonzalez, L; Marquez-Mosquera, L; Gallach, M; Esteve, M; Tremosa, G
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. OP37 Is the withdrawal of anti-tumour necrosis factor in inflammatory bowel disease patients in remission feasible without increasing the risk of relapse? Results from the randomised clinical trial of GETECCU (EXIT). (30th January 2023)

Authors:
Chaparro, M; García Donday, M; Riestra, S; Lucendo, A J; Benítez, J M; Navarro-Llavat, M; Barrio, J; Morales-Alvarado, V J; Rivero, M; Busquets, D; Leo Carnerero, E; Merino Ochoa, O; Nantes Castillejo, O; Navarro, P; Van Domselaar, M; Gutiérrez Casbas, A; Alonso-Abreu, I; Mejuto, R; Fernández Sal...
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i50
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P018 Proteomic profile of serum and urine in newly diagnosed patients with Inflammatory Bowel Disease: new approach for biomarker discovery. (21st January 2022)

Authors:
Baldan-Martin, M; Azkargorta, M; Iloro, I; Ortega Moreno, L; Aldars Garcia, L; Soleto Fernández, I; Ramirez, C; Riestra, S; Rivero, M; Gutierrez, A; Rodríguez-Lago, I; Fernández-Salazar, L; Ceballos, D; Benítez, J M; Aguas, M; Bastón-Rey, I; Bermejo, F; Casanova, M J; Llorente, R; Ber, Y
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i145
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P036 Analysis of intestinal tissue from newly diagnosed patients with inflammatory bowel disease reveals distinct proteomic profiles. (30th January 2023)

Authors:
Baldan-Martin, M; Lloro, I; Azkargorta, M; Ramírez, C; Soleto Fernández, I; Orejudo, M; García, S; Mercado, J; Gordillo, C H; Riestra, S; Rivero, M; Gutiérrez, A; Rodríguez-Lago, I; Fernández-Salazar, L; Ceballos, D; Benítez, J M; Aguas, M; Bastón-Rey, I; Bermejo, F; Casanova, M J
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i202
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. P049 Proteomic characterization of serum extracellular vesicles from newly diagnosed patients with inflammatory bowel disease. (30th January 2023)

Authors:
Soleto, I; Baldan, M; Ramírez, C; Orejudo, M; García, S; Mercado, J; Azkargorta, M; Lloro, I; Ortega Moreno, L; Aldars Garcia, L; Riestra, S; Rivero, M; Gutiérrez, A; Rodríguez-Lago, I; Fernández, L; Ceballos, D; Benítez, J M; Aguas, M; Bastón Rey, I; Bermejo, F
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i217
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗